AgomAb Therapeutics N.V. American Depositary Shares
- AGMB
- NASDAQ
- Biotechnology
- Fibrosis Therapeutics
- Immunology Biotech
$8.23
Today −0.60%Quote Oct 19, 2026, 08:00 PM UTC
−32.37%over the last month
Max drawdown −32.4%From 1-month high −32.4%3 months −29.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About AgomAb Therapeutics N.V. American Depositary Shares
AgomAb Therapeutics N.V. is a clinical-stage biopharmaceutical company dedicated to developing novel, disease-modifying therapies. Its primary focus lies in immunology and inflammatory ailments, particularly chronic fibrotic conditions where significant unmet medical needs persist.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
62
Market value
$281.2M
Quote Oct 19
Analyst target
$35.00
+325.3% from here
Floor
$7.97
3.2% below price
Resistance
$8.62
4.7% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about AGMBPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free